Free Trial
NASDAQ:ADXS

Ayala Pharmaceuticals (ADXS) Stock Price, News & Analysis

Ayala Pharmaceuticals logo
$0.03 0.00 (0.00%)
As of 07/16/2025

About Ayala Pharmaceuticals Stock (NASDAQ:ADXS)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.15
52-Week Range
$0.00
$0.78
Volume
152 shs
Average Volume
5,440 shs
Market Capitalization
$1.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

Ayala Pharmaceuticals, Inc. (ADXS) - Yahoo Finance
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Ayala unit expands cold storage network
Immunome: An Oncology Powerhouse In The Making
See More Headlines

ADXS Stock Analysis - Frequently Asked Questions

Ayala Pharmaceuticals' stock was trading at $0.0270 at the start of the year. Since then, ADXS shares have increased by 23.3% and is now trading at $0.0333.

Ayala Pharmaceuticals, Inc. (NASDAQ:ADXS) posted its quarterly earnings results on Thursday, September, 9th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.02. The company had revenue of $0.25 million for the quarter.

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ayala Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), Madrigal Pharmaceuticals (MDGL), Merck & Co., Inc. (MRK), Acasti Pharma (ACST), Bristol Myers Squibb (BMY) and

Company Calendar

Last Earnings
9/09/2021
Today
7/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ADXS
CIK
1100397
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$3.24 million
Price / Sales
0.44
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.06) per share
Price / Book
-0.02

Miscellaneous

Outstanding Shares
42,633,000
Free Float
42,364,000
Market Cap
$1.42 million
Optionable
Not Optionable
Beta
1.17
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ADXS) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners